{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:20:22Z","timestamp":1773084022743,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-511x-13-185","type":"journal-article","created":{"date-parts":[[2014,12,7]],"date-time":"2014-12-07T02:01:36Z","timestamp":1417917696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients"],"prefix":"10.1186","volume":"13","author":[{"given":"Jinmei","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanle","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,7]]},"reference":[{"issue":"11","key":"1166_CR1","first-page":"870","volume":"16","author":"L Wang","year":"2008","unstructured":"Wang L, Li YM, He FC, Jiang Y: Nonalcoholic fatty liver disease and immune disturbance. Zhonghua Gan Zang Bing Za Zhi. 2008, 16 (11): 870-871. Chinese","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"4","key":"1166_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2013.05.044","volume":"59","author":"F Nascimbeni","year":"2013","unstructured":"Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, Lonardo A: From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013, 59 (4): 859-871. 10.1016\/j.jhep.2013.05.044","journal-title":"J Hepatol"},{"issue":"1","key":"1166_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/gast.2002.34168","volume":"123","author":"E Bugianesi","year":"2002","unstructured":"Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M: Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002, 123 (1): 134-140. 10.1053\/gast.2002.34168","journal-title":"Gastroenterology"},{"issue":"6","key":"1166_CR4","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ: The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association. Hepatology. 2012, 55 (6): 2005-2023. 10.1002\/hep.25762","journal-title":"Hepatology"},{"issue":"3","key":"1166_CR5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM: Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011, 34 (3): 274-285. 10.1111\/j.1365-2036.2011.04724.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"26","key":"1166_CR6","first-page":"447","volume":"111","author":"J Wei\u00df","year":"2014","unstructured":"Wei\u00df J, Rau M, Geier A: Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. Dtsch Arztebl Int. 2014, 111 (26): 447-452.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"1166_CR7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F: The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013, 58 (3): 593-608. 10.1016\/j.jhep.2012.12.005","journal-title":"J Hepatol"},{"issue":"6","key":"1166_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1440-1746.2007.04952.x","volume":"22","author":"JG Fan","year":"2007","unstructured":"Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A: Asia-Pacific Working Party for NAFLD: What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?. J Gastroenterol Hepatol. 2007, 22 (6): 794-800. 10.1111\/j.1440-1746.2007.04952.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"1166_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","volume":"43","author":"JG Fan","year":"2005","unstructured":"Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, Li F, Chen SY: Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol. 2005, 43 (3): 508-514. 10.1016\/j.jhep.2005.02.042","journal-title":"J Hepatol"},{"issue":"47","key":"1166_CR10","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.3748\/wjg.v13.i47.6419","volume":"13","author":"YJ Zhou","year":"2007","unstructured":"Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, Chen MH, Hu PJ: Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol. 2007, 13 (47): 6419-6424. 10.3748\/wjg.v13.i47.6419","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1166_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2036.2004.02012.x","volume":"20","author":"VW Wong","year":"2004","unstructured":"Wong VW, Chan HL, Hui AY, Chan KF, Liew CT, Chan FK, Sung JJ: Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese. Aliment Pharmacol Ther. 2004, 20 (1): 45-49. 10.1111\/j.1365-2036.2004.02012.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1166_CR12","first-page":"425","volume":"116","author":"DM Hurjui","year":"2012","unstructured":"Hurjui DM, Ni\u0163\u0103 O, Graur LI, Mihalache L, Popescu DS, Graur M: The central role of the non alcoholic fatty liver disease in metabolic syndrome. Rev Med Chir Soc Med Nat Iasi. 2012, 116 (2): 425-431.","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"issue":"29","key":"1166_CR13","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.2174\/1381612811319290003","volume":"19","author":"A Lonardo","year":"2013","unstructured":"Lonardo A, Sookoian S, Chonchol M, Loria P, Targher G: Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD. Curr Pharm Des. 2013, 19 (29): 5177-5192. 10.2174\/1381612811319290003","journal-title":"Curr Pharm Des"},{"issue":"10","key":"1166_CR14","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/j.1440-1746.2011.06774.x","volume":"26","author":"LA Adams","year":"2011","unstructured":"Adams LA, George J, Bugianesi E, Rossi E, De Boer WB, van der Poorten D, Ching HL, Bulsara M, Jeffrey GP: Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2011, 26 (10): 1536-1543. 10.1111\/j.1440-1746.2011.06774.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"1166_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1751-2980.2012.00631.x","volume":"13","author":"YH Xun","year":"2012","unstructured":"Xun YH, Fan JG, Zang GQ, Liu H, Jiang YM, Xiang J, Huang Q, Shi JP: Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease. J Dig Dis. 2012, 13 (11): 588-595. 10.1111\/j.1751-2980.2012.00631.x","journal-title":"J Dig Dis"},{"issue":"4","key":"1166_CR16","first-page":"600","volume":"4","author":"RW Yang","year":"2005","unstructured":"Yang RW, Shao ZX, Chen YY, Yin Z, Wang WJ: Lipase and pancreatic amylase activities in diagnosis of acute pancreatitis in patients with hyperamylasemia. Hepatobiliary Pancreat Dis Int. 2005, 4 (4): 600-603.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"6","key":"1166_CR17","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1053\/j.gastro.2013.01.075","volume":"144","author":"BU Wu","year":"2013","unstructured":"Wu BU, Banks PA: Clinical management of patients with acute pancreatitis. Gastroenterology. 2013, 144 (6): 1272-1281. 10.1053\/j.gastro.2013.01.075","journal-title":"Gastroenterology"},{"key":"1166_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000201042","volume":"54","author":"JE Dom\u00ednguez-Mu\u00f1oz","year":"1993","unstructured":"Dom\u00ednguez-Mu\u00f1oz JE, Pieramico O, B\u00fcchler M, Malfertheiner P: Ratios of different serum pancreatic enzymes in the diagnosis and staging of chronic pancreatitis. Digestion. 1993, 54: 231-236. 10.1159\/000201042","journal-title":"Digestion"},{"key":"1166_CR19","doi-asserted-by":"publisher","first-page":"16S","DOI":"10.1097\/01.ALC.0000078827.46112.76","volume":"27","author":"K Maruyama","year":"2003","unstructured":"Maruyama K, Takahashi H, Okuyama K, Yokoyama A, Nakamura Y, Kobayashi Y, Ishii H: Low serum amylase levels in drinking alcoholics. Alcohol Clin Exp Res. 2003, 27: 16S-21S. 10.1097\/01.ALC.0000078827.46112.76","journal-title":"Alcohol Clin Exp Res"},{"key":"1166_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/jcp.37.3.302","volume":"37","author":"P Dandona","year":"1984","unstructured":"Dandona P, Freedman DB, Foo Y, Rosalki SB, Beckett AG: Exocrine pancreatic function in diabetes mellitus. J Clin Pathol. 1984, 37: 302-306. 10.1136\/jcp.37.3.302","journal-title":"J Clin Pathol"},{"key":"1166_CR21","first-page":"73","volume":"26","author":"AA Aughsteen","year":"2005","unstructured":"Aughsteen AA, Abu-Umair MS, Mahmoud SA: Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus. Saudi Med J. 2005, 26: 73-77.","journal-title":"Saudi Med J"},{"issue":"19\u201320","key":"1166_CR22","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cca.2011.06.023","volume":"412","author":"JG Lee","year":"2011","unstructured":"Lee JG, Park SW, Cho BM, Lee S, Kim YJ, Jeong DW, Yi YH, Cho YH: Serum amylase and risk of the metabolic syndrome in Korean adults. Clin Chim Acta. 2011, 412 (19\u201320): 1848-1853.","journal-title":"Clin Chim Acta"},{"key":"1166_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1475-2840-10-34","volume":"10","author":"K Nakajima","year":"2011","unstructured":"Nakajima K, Nemoto T, Muneyuki T, Kakei M, Fuchigami H, Munakata H: Low serum amylase in association with metabolic syndrome and diabetes: a community-based study. Cardiovasc Diabetol. 2011, 10: 34- 10.1186\/1475-2840-10-34","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"1166_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/00365513.2013.878469","volume":"74","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Zhang J, Zhang J, Wu J, Chen Y: Metabolic syndrome and diabetes are associated with low serum amylase in a Chinese asymptomatic population. Scand J Clin Lab Invest. 2014, 74 (3): 235-239. 10.3109\/00365513.2013.878469","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"1166_CR25","doi-asserted-by":"publisher","first-page":"e002235","DOI":"10.1136\/bmjopen-2012-002235","volume":"3","author":"K Nakajima","year":"2013","unstructured":"Nakajima K, Oshida H, Muneyuki T, Saito M, Hori Y, Fuchigami H, Kakei M, Munakata H: Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study. BMJ Open. 2013, 3 (1): e002235-","journal-title":"BMJ Open"},{"key":"1166_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1475-2840-12-77","volume":"12","author":"WC Wu","year":"2013","unstructured":"Wu WC, Wang CY: Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case\u2013control retrospective study. Cardiovasc Diabetol. 2013, 12: 77- 10.1186\/1475-2840-12-77","journal-title":"Cardiovasc Diabetol"},{"key":"1166_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1186\/1471-2458-13-1045","volume":"13","author":"X Sun","year":"2013","unstructured":"Sun X, Du T, Huo R, Yu X, Xu L: I mpact of HbA1c criterion on the definition of glycemic component of the metabolic syndrome: the China health and nutrition survey 2009. BMC Public Health. 2013, 13: 1045- 10.1186\/1471-2458-13-1045","journal-title":"BMC Public Health"},{"issue":"10","key":"1166_CR28","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.2337\/dc10-0433","volume":"33","author":"DE Olson","year":"2010","unstructured":"Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS: Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care. 2010, 33 (10): 2184-2189. 10.2337\/dc10-0433","journal-title":"Diabetes Care"},{"issue":"2","key":"1166_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1751-2980.2008.00331.x","volume":"9","author":"MD Zeng","year":"2008","unstructured":"Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY, Mao YM: Chinese national consensus workshop on nonalcoholic fatty liver disease: guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis. 2008, 9 (2): 108-112. 10.1111\/j.1751-2980.2008.00331.x","journal-title":"J Dig Dis"},{"issue":"4","key":"1166_CR30","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1038\/srep05832","volume":"25","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhao Y, Xu C, Hong Y, Lu H, Wu J, Chen Y: Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. Sci Rep. 2014, 25 (4): 5832-","journal-title":"Sci Rep"},{"issue":"3","key":"1166_CR31","first-page":"163","volume":"18","author":"F Jian-gao","year":"2010","unstructured":"Jian-gao F: Chinese liver disease association: guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition. Zhonghua Gan Zang Bing Za Zhi. 2010, 18 (3): 163-166.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"7","key":"1166_CR32","doi-asserted-by":"publisher","first-page":"e68780","DOI":"10.1371\/journal.pone.0068780","volume":"8","author":"B Chen","year":"2013","unstructured":"Chen B, Ye B, Zhang J, Ying L, Chen Y: RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PLoS One. 2013, 8 (7): e68780- 10.1371\/journal.pone.0068780","journal-title":"PLoS One"},{"issue":"3","key":"1166_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3350\/cmh.2013.19.3.258","volume":"19","author":"HM Kim","year":"2013","unstructured":"Kim HM, Kim BS, Cho YK, Kim BI, Sohn CI, Jeon WK, Kim HJ, Park DI, Park JH, Joo KJ, Kim CJ, Kim YS, Heo WJ, Choi WS: Elevated red cell distribution width is associated with advanced fibrosis in NAFLD. Clin Mol Hepatol. 2013, 19 (3): 258-265. 10.3350\/cmh.2013.19.3.258","journal-title":"Clin Mol Hepatol"},{"issue":"12","key":"1166_CR34","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1210\/jc.2006-0587","volume":"91","author":"KM Utzschneider","year":"2006","unstructured":"Utzschneider KM, Kahn SE: Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2006, 91 (12): 4753-4761. 10.1210\/jc.2006-0587","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1166_CR35","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.bbadis.2014.08.004","volume":"1842","author":"N Gruben","year":"2014","unstructured":"Gruben N, Shiri-Sverdlov R, Koonen DP, Hofker MH: Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison?. Biochim Biophys Acta. 2014, 1842 (11): 2329-2343. 10.1016\/j.bbadis.2014.08.004","journal-title":"Biochim Biophys Acta"},{"issue":"31","key":"1166_CR36","doi-asserted-by":"publisher","first-page":"22678","DOI":"10.1074\/jbc.M704213200","volume":"282","author":"CS Choi","year":"2007","unstructured":"Choi CS, Savage DB, Kulkarni A, Yu XX, Liu ZX, Morino K, Kim S, Distefano A, Samuel VT, Neschen S, Zhang D, Wang A, Zhang XM, Kahn M, Cline GW, Pandey SK, Geisler JG, Bhanot S, Monia BP, Shulman GI: Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J Biol Chem. 2007, 282 (31): 22678-22688. 10.1074\/jbc.M704213200","journal-title":"J Biol Chem"},{"issue":"6","key":"1166_CR37","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.2337\/db12-1397","volume":"62","author":"SM Chan","year":"2013","unstructured":"Chan SM, Sun RQ, Zeng XY, Choong ZH, Wang H, Watt MJ, Ye JM: Activation of PPAR\u03b1 ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes. 2013, 62 (6): 2095-2105. 10.2337\/db12-1397","journal-title":"Diabetes"},{"issue":"5","key":"1166_CR38","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.biocel.2003.10.002","volume":"36","author":"PJ Klover","year":"2004","unstructured":"Klover PJ, Mooney RA: Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol. 2004, 36 (5): 753-758. 10.1016\/j.biocel.2003.10.002","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"1166_CR39","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","volume":"15","author":"FR Jornayvaz","year":"2012","unstructured":"Jornayvaz FR, Shulman GI: Diacylglycerol activation of protein kinase C\u03f5 and hepatic insulin resistance. Cell Metab. 2012, 15 (5): 574-584. 10.1016\/j.cmet.2012.03.005","journal-title":"Cell Metab"},{"issue":"5","key":"1166_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/labinvest.2014.11","volume":"94","author":"W Liang","year":"2014","unstructured":"Liang W: Lindeman JH2, Menke AL3, Koonen DP4, Morrison M5, Havekes LM1, van den Hoek AM5, Kleemann R6: Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1\u03b2-induced chronic inflammation. Lab Invest. 2014, 94 (5): 491-502. 10.1038\/labinvest.2014.11","journal-title":"Lab Invest"},{"issue":"2","key":"1166_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1053\/j.gastro.2012.06.004","volume":"143","author":"E Seki","year":"2012","unstructured":"Seki E, Brenner DA, Karin M: A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology. 2012, 143 (2): 307-320. 10.1053\/j.gastro.2012.06.004","journal-title":"Gastroenterology"},{"issue":"1","key":"1166_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","volume":"51","author":"G Baffy","year":"2009","unstructured":"Baffy G: Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol. 2009, 51 (1): 212-223. 10.1016\/j.jhep.2009.03.008","journal-title":"J Hepatol"},{"key":"1166_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1475-2840-11-80","volume":"11","author":"T Muneyuki","year":"2012","unstructured":"Muneyuki T, Nakajima K, Aoki A, Yoshida M, Fuchigami H, Munakata H, Ishikawa SE, Sugawara H, Kawakami M, Momomura S, Kakei M: Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adults. Cardiovasc Diabetol. 2012, 11: 80- 10.1186\/1475-2840-11-80","journal-title":"Cardiovasc Diabetol"},{"key":"1166_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/1756-0500-4-419","volume":"4","author":"K Nakajima","year":"2011","unstructured":"Nakajima K, Muneyuki T, Munakata H, Kakei M: Revisiting the cardiometabolic relevance of serum amylase. BMC Res Notes. 2011, 4: 419- 10.1186\/1756-0500-4-419","journal-title":"BMC Res Notes"},{"key":"1166_CR45","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.mcna.2007.06.012","volume":"91","author":"D Lann","year":"2007","unstructured":"Lann D, LeRoith D: Insulin resistance as the underlying cause for the metabolic syndrome. Med Clin North Am. 2007, 91: 1063-1077. 10.1016\/j.mcna.2007.06.012","journal-title":"Med Clin North Am"},{"key":"1166_CR46","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1097\/MPA.0b013e3181744b50","volume":"37","author":"X Zhang","year":"2008","unstructured":"Zhang X, Cui Y, Fang L, Li F: Chronic high-fat diets induce oxide injuries and fibrogenesis of pancreatic cells in rats. Pancreas. 2008, 37: e31-e38. 10.1097\/MPA.0b013e3181744b50","journal-title":"Pancreas"},{"issue":"8","key":"1166_CR47","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/MPA.0b013e3181f6fce2","volume":"39","author":"EJ van Geenen","year":"2010","unstructured":"van Geenen EJ, Smits MM, Schreuder TC, van der Peet DL, Bloemena E, Mulder CJ: Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas. 2010, 39 (8): 1185-1190. 10.1097\/MPA.0b013e3181f6fce2","journal-title":"Pancreas"},{"issue":"5","key":"1166_CR48","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.gie.2011.01.015","volume":"73","author":"PS Sepe","year":"2011","unstructured":"Sepe PS, Ohri A, Sanaka S, Berzin TM, Sekhon S, Bennett G, Mehta G, Chuttani R, Kane R, Pleskow D, Sawhney MS: A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc. 2011, 73 (5): 987-993. 10.1016\/j.gie.2011.01.015","journal-title":"Gastrointest Endosc"},{"key":"1166_CR49","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1210\/en.2004-0478","volume":"145","author":"I Kharroubi","year":"2004","unstructured":"Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL: Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology. 2004, 145: 5087-5096. 10.1210\/en.2004-0478","journal-title":"Endocrinology"},{"issue":"2","key":"1166_CR50","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","volume":"20","author":"Y Sumida","year":"2014","unstructured":"Sumida Y, Nakajima A, Itoh Y: Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol. 2014, 20 (2): 475-485. 10.3748\/wjg.v20.i2.475","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1166_CR51","doi-asserted-by":"publisher","first-page":"e58360","DOI":"10.1371\/journal.pone.0058360","volume":"8","author":"M Demir","year":"2013","unstructured":"Demir M, Lang S, Schlattjan M, Drebber U, Wedemeyer I, Nierhoff D, Kaul I, Sowa J, Canbay A, T\u00f6x U, Steffen HM: NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD. PLoS One. 2013, 8 (3): e58360- 10.1371\/journal.pone.0058360","journal-title":"PLoS One"},{"issue":"2","key":"1166_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/13651820701286177","volume":"9","author":"HA Pitt","year":"2007","unstructured":"Pitt HA: Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford). 2007, 9 (2): 92-97. 10.1080\/13651820701286177","journal-title":"HPB (Oxford)"},{"issue":"6","key":"1166_CR53","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/apt.12237","volume":"37","author":"NS Patel","year":"2013","unstructured":"Patel NS, Peterson MR, Brenner DA, Heba E, Sirlin C, Loomba R: Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013, 37 (6): 630-639. 10.1111\/apt.12237","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-13-185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T13:53:01Z","timestamp":1690725181000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-13-185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1166"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-13-185","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"30 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"185"}}